Value of Ischemia and Coronary Anatomy in Prognosis and Guiding Revascularization Among Patients With Stable Ischemic Heart Disease

被引:0
|
作者
Patel, Krishna K. [1 ]
Peri-Okonny, Poghni A. [2 ]
Giorgetti, Assuero [3 ]
Shaw, Leslee J. [1 ]
Gimelli, Alessia [3 ]
机构
[1] Icahn Sch Med Mt Sinai, Blavatnik Family Womens Hlth Res Inst, Zena & Michael A Weiner Cardiovasc Inst, Dept Med Cardiol & Populat Hlth Sci & Policy, 1425 Madison Ave,L2-33, New York, NY 10025 USA
[2] Yale Univ, Dept Med Cardiol, Sch Med, New Haven, CT USA
[3] Fdn Toscana Gabriele Monasterio, Dept Imaging, Pisa, Italy
基金
美国国家卫生研究院;
关键词
coronary artery disease; death; humans; myocardial perfusion imaging; risk factors; POSITRON-EMISSION-TOMOGRAPHY; ARTERY-DISEASE; RISK STRATIFICATION; CLINICAL-OUTCOMES; SURVIVAL BENEFIT; TERM SURVIVAL; PREDICTION; THERAPY; SURGERY; SCORE;
D O I
10.1161/CIRCIMAGING.123.016587
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: The value of physiological ischemia versus anatomic severity of disease for prognosis and management of patients with stable coronary artery disease (CAD) is widely debated. METHODS: A total of 1764 patients who had rest-stress cadmium-zinc-telluride single-photon emission computed tomography myocardial perfusion imaging and angiography (invasive or computed tomography) were prospectively enrolled and followed for cardiac death/nonfatal myocardial infarction. The CAD prognostic index (CADPI) was used to quantify the extent and severity of angiographic disease. Prognostic value was assessed using Cox models, adjusted for pretest risk, known CAD, stressor, left ventricular ejection fraction, %ischemia and infarct, CADPI, and early (90-day) revascularization. Incremental prognostic value was evaluated using net reclassification index. RESULTS: The mean age was 69.7 +/- 9.5 years, 24.4% were women, and 29.3% had known CAD. Significant ischemia (>10%) was present in 28.4%. Nonobstructive, single, and multivessel disease was present in 256 (14.5%), 772 (43.8%), and 736 (41.7%), respectively. Early revascularization occurred in 579 (32.8%). Cardiac death/myocardial infarction occurred in 148 (8.4%) over a 4.6-year median follow-up. Both %ischemia and CADPI provided independent and incremental prognostic value over pretest clinical risk (P<0.001). In a model containing both ischemia and anatomy, ischemia was prognostic (hazard ratio per 5% up arrow, 1.35 [95% CI, 1.11-1.63]; P=0.002) but CADPI was not (hazard ratio per 10-unit up arrow, 1.09 [95% CI, 0.99-1.20]; P=0.07). Early revascularization modified the risk associated with %ischemia (interaction P=0.003) but not with CADPI (interaction P=0.6). %Ischemia and single-photon emission computed tomography variables added incremental prognostic value over clinical risk and CADPI (net reclassification index, 20.3% [95% CI, 9%-32%]; P<0.05); however, CADPI was not incrementally prognostic beyond pretest risk, %ischemia, and single-photon emission computed tomography variables (net reclassification index, 3.1% [95% CI, -5% to 15%]; P=0.21). CONCLUSIONS: Ischemic burden provides independent and incremental prognostic value beyond CAD anatomy and identifies patients who benefit from early revascularization. The anatomic extent of disease has independent prognostic value over clinical risk factors but offers limited incremental benefit for prognosis and guiding revascularization beyond physiological severity (ischemia).
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Impact of coronary revascularization vs medical therapy on ischemia among stable patients with or suspected coronary artery disease undergoing serial myocardial perfusion scintigraphy
    Nudi, Francesco
    Di Belardino, Natale
    Versaci, Francesco
    Pinto, Annamaria
    Procaccini, Enrica
    Neri, Giandomenico
    Vetere, Maurizio
    Frati, Giacomo
    Peruzzi, Mariangela
    Schillaci, Orazio
    Gaspardone, Achille
    Tomai, Fabrizio
    Biondi-Zoccai, Giuseppe
    JOURNAL OF NUCLEAR CARDIOLOGY, 2017, 24 (05) : 1690 - 1698
  • [22] Septal Myectomy in patients with previous coronary revascularization - hypertrophic cardiomyopathy masquerading as ischemic heart disease
    Mathew, Jessey
    Nguyen, Anita
    Nishimura, Rick A.
    Geske, Jeffrey B.
    Dearani, Joseph A.
    Ommen, Steve R.
    Lahr, Brian D.
    Schaff, Hartzell, V
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2020, 319 : 97 - 100
  • [23] Impact of coronary revascularization vs medical therapy on ischemia among stable patients with or suspected coronary artery disease undergoing serial myocardial perfusion scintigraphy
    Francesco Nudi
    Natale Di Belardino
    Francesco Versaci
    Annamaria Pinto
    Enrica Procaccini
    Giandomenico Neri
    Maurizio Vetere
    Giacomo Frati
    Mariangela Peruzzi
    Orazio Schillaci
    Achille Gaspardone
    Fabrizio Tomai
    Giuseppe Biondi-Zoccai
    Journal of Nuclear Cardiology, 2017, 24 : 1690 - 1698
  • [24] Lessons Learned from the ISCHEMIA Trial for the Management of Patients with Stable Ischemic Heart Disease
    Boden, William E.
    Stone, Peter H.
    ANNUAL REVIEW OF MEDICINE, 2023, 74 : 189 - 198
  • [25] The prognostic significance of coronary collaterals in patients with ischemic heart disease: An essential response to ischemia
    Celik, Turgay
    Iyisoy, Atila
    Yuksel, Cagdas U.
    Celik, Murat
    Isik, Ersoy
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2010, 138 (01) : 101 - 103
  • [26] The elusive role of myocardial perfusion imaging in stable ischemic heart disease: Is ISCHEMIA the answer?
    Xie, Joe X.
    Winchester, David E.
    Phillips, Lawrence M.
    Hachamovitch, Rory
    Berman, Daniel S.
    Blankstein, Ron
    Di Carli, Marcelo F.
    Miller, Todd D.
    Al-Mallah, Mouaz H.
    Shaw, Leslee J.
    JOURNAL OF NUCLEAR CARDIOLOGY, 2017, 24 (05) : 1610 - 1618
  • [27] Medical and Revascularization Management of Stable Ischemic Heart Disease: An Overview
    Radaideh, Qais
    Shammas, Nicolas W.
    Daher, Ghassan E.
    Rachwan, Rayan Jo
    INTERNATIONAL JOURNAL OF ANGIOLOGY, 2021, 30 (01) : 83 - 89
  • [28] Revascularization in Stable Ischemic Heart Disease: Whether to Change the Approach?
    Bershtein, L. L.
    Katamadze, N. O.
    Golovina, A. E.
    Sayganov, S. A.
    KARDIOLOGIYA, 2016, 56 (04) : 66 - 74
  • [29] Darapladib for Preventing Ischemic Events in Stable Coronary Heart Disease
    White, Harvey D.
    Held, Claes
    Stewart, Ralph
    Tarka, Elizabeth
    Brown, Rebekkah
    Davies, Richard Y.
    Budaj, Andrzej
    Harrington, Robert A.
    Steg, P. Gabriel
    Ardis-Sino, Diego
    Armstrong, Paul W.
    Avezum, Alvaro
    Aylward, Philip E.
    Bryce, Alfonso
    Chen, Hong
    Chen, Ming-Fong
    Corbalan, Ramon
    Dalby, Anthony J.
    Danchin, Nicolas
    De Winter, Robbert J.
    Denchev, Stefan
    Diaz, Rafael
    Elisaf, Moses
    Flather, Marcus D.
    Goudev, Assen R.
    Granger, Christopher B.
    Grinfeld, Liliana
    Hochman, Judith S.
    Husted, Steen
    Kim, Hyo-Soo
    Koenig, Wolfgang
    Linhart, Ales
    Lonn, Eva
    Lopez-Sendon, Jose
    Manolis, Athanasios J.
    Mohler, Emile R., III
    Nicolau, Jose C.
    Pais, Prem
    Parkhomenko, Alexander
    Pedersen, Terje R.
    Pella, Daniel
    Ramos-Corrales, Marco A.
    Ruda, Mikhail
    Sereg, Mtys
    Siddique, Saulat
    Sinnaeve, Peter
    Smith, Peter
    Sritara, Piyamitr
    Swart, Henk P.
    Sy, Rody G.
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (18) : 1702 - 1711
  • [30] Stable Coronary Syndromes The Case for Consolidating the Nomenclature of Stable Ischemic Heart Disease
    Berry, Colin
    CIRCULATION, 2017, 136 (05) : 437 - 439